Cargando…
艾曲泊帕治疗儿童原发免疫性血小板减少症23例临床观察
OBJECTIVE: To evaluate the efficacy and safety of eltrombopag in the treatment of pediatric primary immune thrombocytopenia (ITP) . METHODS: The clinical characteristics of 23 pediatric ITP patients who received eltrombopag from May 2015 to March 2019 were retrospectively analyzed. Eltrombopag start...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342689/ https://www.ncbi.nlm.nih.gov/pubmed/32023736 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.012 |